Verso Biosense, an innovative femtech company, has created a series of smart intrauterine sensors designed to monitor biomarkers in the uterus, like core body temperature and oxygen. These sensors are integrated into smart accessories that power the device and transmit the data to an interactive app, providing valuable insights into uterine health.
Supported by axess sexual health, Verso Biosense is seeking women aged 18-42 with normal menstrual cycles to take part in a study evaluating the intrauterine device.
The study runs for seven days and clinical teams at axess will offer full support to participants throughout the trial. Participants will be compensated for their time.
Axess’ Liverpool and Knowsley locations (The Beat and The Arch, respectively) are two centres enrolling women into the clinical trial.
Speaking with axess, Nadia Whittley, Verso Biosense CEO said:
“Despite its significance for life, our understanding of uterine health – what’s considered ‘normal’ and the changes that indicate dysfunction or disease – is surprisingly limited. This is because wombs are hard to access. The scientific understanding that we currently have is largely taken from single moments in time.’’
“That’s where the Verso Biosense technology comes in. Imagine a future where we could continuously monitor uterine health in a non-surgical and proactive way, instead of waiting for a critical problem to arise. This is the promise of the Verso Biosense technology. By providing continuous, accurate, real-time data, our innovative solution could allow us to build a deeper understanding of uterine conditions over time.’’
“By combining our data with insights about lifestyle, for instance, we could develop a more holistic and personalised approach to uterine health, and ultimately, women’s wellness.”
According to Nadia, the power is in the data: “By identifying patterns and fluctuations of temperature and other biomarkers, we can empower women and their healthcare providers with information, moving from reactive to preventative care in a personalised way. We want to help bridge the gaps in understanding around uterine health and transform women’s health for the better.”
To learn more about this clinical trial, visit clinicaltrials.versobiosense.com.
If you’d like to participate in the trial at axess, contact our Research Team at axessresearch@liverpoolft.nhs.uk.
